相关实验视频
Updated: Jun 28, 2025
06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.6K
超偏磁铁氧化物纳米粒子重编程瘤微环境,减少肺癌在克里佐替尼治疗后复发
Natalie K Horvat1,2,3, Sara Chocarro4,3, Oriana Marques1,2
1Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 350, 69120, Heidelberg, Germany.
ACS nano
|April 16, 2024
概括
超偏磁铁氧化物纳米粒子重新编程与瘤相关的巨细胞,以对抗ALK阳性肺癌. 这种新疗法延缓瘤生长,并阻止氨酸激酶抑制剂治疗后的再生长,改善了耐药瘤的结果.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 阳性ALK非小细胞肺癌 (NSCLC) 患者最初对ALK氨酸激酶抑制剂 (TKIs) 有反应,但发展出耐药性,导致生存率低下.
- 瘤相关巨细胞 (TAMs) 促进肺癌生长和免疫抑制,阻碍ALK阳性NSCLC的有效免疫治疗.
- 将TAM重编程为一种促炎性,抑制瘤的表型是一种有前途的治疗策略.
研究的目的:
- 研究含有核心交联聚合物微粒 (SPION-CCPMs) 的超偏磁铁氧化物纳米颗粒在重编程TAM中的有效性.
- 评估SPION-CCPMs增强抗瘤免疫力和克服ALK阳性肺癌中TKI耐药性的能力.
- 评估SPION-CCPMs作为辅助疗法,以改善ALK阳性NSCLC患者的存活率.
主要方法:
- SPION-CCPMs被合成并以其向巨细胞的能力为特征.
- 该研究评估了SPION-CCPMs对TAM表型,细胞因子分泌和活性物种生产的影响.
- 在体内研究涉及SPION-CCPMs在ALK阳性肺癌小鼠模型中的内灌注,与TKI治疗相结合.
主要成果:
- SPION-CCPMs刺激TAMs分泌瘤杀伤性反应性物种和细胞因子.
- 通过招募CD8+T细胞,SPION-CCPMs重塑了免疫抑制性瘤微环境 (TME).
- 在小鼠的TKI治疗后,静脉内施用SPION-CCPM延缓了瘤生长,并停止了瘤再生.
结论:
- SPION-CCPM有效地重编程TAM,表现出直接的瘤杀伤活性,并将TME重塑为细胞毒性.
- SPION-CCPMs显示出作为辅助疗法的显著潜力,以克服TKI耐药性并延迟ALK阳性NSCLC中耐药瘤的出现.
- 这种纳米医疗方法提供了一种新的策略,可以在以前没有反应的ALK阳性肺癌患者中增强免疫疗法反应.
相关概念视频
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K